EXTRAORDINARY GENERAL MEETING CONCLUDED
04.01.2024
EGM Notice Correction
15.12.2023
Notice of an extraordinary general meeting
14.12.2023
SIGNIFICANT NEW INVESTMENT OF NOK 144 MILLION FROM HOFSETH INTERNATIONAL INTO HBC
13.12.2023
DISCLOSURE OF LARGE SHAREHOLDING
27.11.2023
MANDATORY NOTIFICATION OF TRADE
30.12.2022
THIRD QUARTER 2022 FINANCIAL REPORT
11.11.2022
STANFORD SCHOOL OF MEDICINE SUCCESSFULLY COMPLETES PRE-CLINICAL TRIAL WORK TESTING PROGO® BIOACTIVE PEPTIDES IN EFFECTIVE GUT HEALTH SUPPORT
17.10.2022
COMPLETED EXTRAORDINARY GENERAL MEETING
30.08.2022